Hour Loop (NASDAQ:HOUR) reported quarterly losses of $(0.01) per share. The company reported $14.80 million in sales this quarter.
Intravenous DMT Therapy Seeks Ideal Dosage For Stroke And TBI Treatment
Canadian biopharma company Algernon Pharmaceuticals Inc.